A Reversal for STEREOTAXIS INC (NYSEAMERICAN:STXS) Is Near. The Stock Has Decrease in Shorts

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Logo

Investors sentiment is 0 in Q1 2019. Its the same as in 2018Q4. It is the same, as 0 investors sold Stereotaxis, Inc. shares while 0 reduced holdings. only 0 funds opened positions while 0 raised stakes. 13.69 million shares or 0.00% without change from 13.69 million shares in 2018Q4 were reported.
Dafna Capital Management Ltd Limited Liability Company stated it has 11.51% of its portfolio in Stereotaxis, Inc. (NYSEAMERICAN:STXS). Everett Harris & Company Ca reported 11,900 shares.

The stock of STEREOTAXIS INC (NYSEAMERICAN:STXS) registered a decrease of 0.59% in short interest. STXS’s total short interest was 135,700 shares in September as published by FINRA. Its down 0.59% from 136,500 shares, reported previously. With 77,800 shares average volume, it will take short sellers 2 days to cover their STXS’s short positions.

The stock increased 3.45% or $0.12 during the last trading session, reaching $3.6. About 29,464 shares traded. Stereotaxis, Inc. (NYSEAMERICAN:STXS) has 0.00% since September 11, 2018 and is . It has by 0.00% the S&P500.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. The company has market cap of $213.92 million. The Company’s products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. It currently has negative earnings. The firm also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks worldwide.

More notable recent Stereotaxis, Inc. (NYSEAMERICAN:STXS) news were published by: Seekingalpha.com which released: “Medical Robotics: Interesting Prospects On The Horizon – Seeking Alpha” on September 06, 2019, also Marketwatch.com with their article: “These are the most profitable Nasdaq biotech companies – MarketWatch” published on March 02, 2015, Streetinsider.com published: “Stereotaxis (STXS) Announces Growth of Second System Orders – StreetInsider.com” on October 04, 2012. More interesting news about Stereotaxis, Inc. (NYSEAMERICAN:STXS) were released by: Globenewswire.com and their article: “Stereotaxis Announces Uplisting to NYSE American Other OTC:STXS – GlobeNewswire” published on September 03, 2019 as well as Stockhouse.com‘s news article titled: “Stereotaxis to Report Second Quarter 2019 Financial Results on August 8, 2019 – Stockhouse” with publication date: August 07, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.